Concord Biotech Ltd. (CONCORDBIO)
Market Closed
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
1,419. 00
+54
+3.956%
₹
229.78B Market Cap
- P/E Ratio
35% Div Yield
360,085 Volume
- Eps
₹ 1,365
Previous Close Want to track CONCORDBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 7.1 | 6.31 |
| | | 4.8 | 6.03 |
| | | 10.2 | 13.42 |
| | | 7.8 | 7.41 |
CONCORDBIO Earnings Reports FAQ
What is the earnings per share (EPS) for CONCORDBIO?
EPS data for CONCORDBIO is currently not available, as Concord Biotech Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately -7.72%, reflecting the CONCORDBIO's performance and XNSE market conditions.
When is the next earnings release date?
Concord Biotech Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Concord Biotech Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CONCORDBIO at this time, as Concord Biotech Ltd has no recent EPS data to calculate it.
